Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Progenics Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
MedImmune Enters Into Licensing Agreement With Progenics Pharma For Clostridium Difficile Preclinical Program 12
Exini Diagnostics Enters into Agreement with DexTech Medical for OsteoDex 13
Licensing Agreements 14
Progenics Pharma Enters into Licensing Agreement with Selexis 14
Bayer Enters into Licensing Agreement with Progenics Pharma 15
Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins University 16
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 17
ITM Isotopen Enters Into Licensing Agreement With Progenics Pharma For Dotatoc 18
Equity Offering 19
Progenics Pharma Plans to Raise up to USD75 Million in Public Offering of Shares 19
Progenics Pharma Prices Public Offering of Shares for USD75 Million 20
Progenics Pharma Completes Public Offering Of Shares For US$35 Million 22
Progenics Pharma Completes Public Offering Of Shares For US$37 Million 23
Progenics Pharma Completes Public Offering Of Common Stock For US$25 Million 24
Asset Transactions 26
CytoDyn Completes Acquisition Of PRO 140 From Progenics Pharma 26
Acquisition 28
Progenics Pharma Acquires Molecular Insight Pharma for up to USD106 Million 28
Progenics Pharmaceuticals Inc – Key Competitors 30
Progenics Pharmaceuticals Inc – Key Employees 31
Progenics Pharmaceuticals Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Jul 31, 2018: Azedra’s approval, progenics pharmaceuticals announces second quarter 2018 financial results and business update 33
May 09, 2018: Progenics Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update 36
Mar 08, 2018: Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update 38
Nov 02, 2017: Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update 40
Aug 09, 2017: Progenics Pharmaceuticals Announces Second Quarter 2017 Financial Results and Business Update 42
May 04, 2017: Progenics Pharmaceuticals Announces First Quarter 2017 Financial Results and Business Update 44
Mar 09, 2017: Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2016 Financial Results and Business Update 46
Clinical Trials 48
Dec 06, 2017: First gastroenteropancreatic-neuroendocrine tumor (GEP-NET) patient in Europe for the COMPETE phase III clinical trial with n.c.a. 177Lu-Edotreotide (Solucin) 48
Nov 14, 2017: Successful Hosting of the Investigator Meeting for Phase III Clinical Trial COMPETE with n.c.a. 177Lu-Edotreotide (Solucin) in Cancer Patients with GEP-NET 50
Feb 14, 2017: Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Progenics Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Progenics Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
MedImmune Enters Into Licensing Agreement With Progenics Pharma For Clostridium Difficile Preclinical Program 12
Exini Diagnostics Enters into Agreement with DexTech Medical for OsteoDex 13
Progenics Pharma Enters into Licensing Agreement with Selexis 14
Bayer Enters into Licensing Agreement with Progenics Pharma 15
Progenics Pharmaceuticals Enters into Licensing Agreement with Johns Hopkins University 16
Molecular Insight Pharma Enters into Licensing Agreement with University of Zurich and Paul Scherrer Institute 17
ITM Isotopen Enters Into Licensing Agreement With Progenics Pharma For Dotatoc 18
Progenics Pharma Plans to Raise up to USD75 Million in Public Offering of Shares 19
Progenics Pharma Prices Public Offering of Shares for USD75 Million 20
Progenics Pharma Completes Public Offering Of Shares For US$35 Million 22
Progenics Pharma Completes Public Offering Of Shares For US$37 Million 23
Progenics Pharma Completes Public Offering Of Common Stock For US$25 Million 24
CytoDyn Completes Acquisition Of PRO 140 From Progenics Pharma 26
Progenics Pharma Acquires Molecular Insight Pharma for up to USD106 Million 28
Progenics Pharmaceuticals Inc, Key Competitors 30
Progenics Pharmaceuticals Inc, Key Employees 31
Progenics Pharmaceuticals Inc, Subsidiaries 32
List of Figures
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Progenics Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Progenics Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer